Users Stopping Weight-Loss Jabs Regain Weight Far More Rapidly Than Dieters

A recent study suggests that individuals who come off popular GLP-1 drugs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who stop conventional lifestyle programs.

Published data in a leading medical journal shows that while obese individuals can lose substantial amounts of their total mass while using the jabs, the weight returns at an average rate of 0.8 kg per month after stopping.

"Individuals purchasing such treatments should be cognizant of the potential of fast rebound weight gain when the therapy ends," cautioned researcher Dr. Susan Jebb.

Such speed of regain implies a return to original mass in about one and a half years.

Weighing Treatments

The research, which examined dozens of trials involving over 9,000 of participants, contrasted the effects of these new drugs with older methods.

Scientists point out that people who shed pounds through dieting usually have a more gradual creep back—perhaps 100 grams monthly—post-intervention.

Understanding the Fast Regain

Experts propose the mode of action of the injections is key to understanding the accelerated regain.

These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Long-term administration of GLP-1 concentrations far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement means hunger is no longer kept in check, making binge eating a significant risk."

A Lifelong Condition?

Health authorities advise the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Many experts say that, given the likelihood of relapse, the treatment might need to be life-long.

This opinion is reinforced by pharmaceutical companies, who note that the findings "underscore the chronic character of obesity," comparing it to managing diseases like hypertension.

Patient Testimonies

People who have come off the jabs explain a sudden return of appetite.

"It felt as if a switch that goes on and I was suddenly starving," said a patient.

This challenge is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.

Widespread Use

Figures indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.

• Use is higher among females than men.
• The 40s and 50s age group shows the highest usage rates.
• Many obtain the drugs through private healthcare rather than public health services.

Finally, experts stress that while the jabs are powerful agents for shedding pounds, they are not a magic solution and lasting health benefits relies on integrated behavioural management.